EMBO Young Investigator and EMBO Member
Anna C. Obenauf
EMBO 2023 | MemC 24–27
Research Institute of Molecular Pathology (IMP), Vienna, Austria
Combination therapies for metastatic cancer
My lab studies the molecular mechanisms underlying tumor progression and immune evasion. Our work is inspired by clinical puzzles and we develop and apply innovative technologies to dissect complex disease phenotypes in experimentally tractable cancer models. We seek to deliver both, insights into general molecular principles from gene regulation to immunity, and scientific evidence to guide the development of combination therapies in the clinic.
Keywords
Cancer biology / tumor microenvironment / tumor immunology / therapy resistance / immunotherapy / metastasis / technology development / tumor evolution